Biologic Drugs With Mechanism of Action: Interleukin-5 Antagonists
✉ Email this page to a colleague
Biologic Drugs With Mechanism of Action: Interleukin-5 Antagonists
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Glaxosmithkline Llc | NUCALA | mepolizumab | For Injection | 125526 | 2015-11-04 | ⤷ Subscribe | ⤷ Subscribe |
Teva Respiratory, Llc | CINQAIR | reslizumab | Injection | 761033 | 2016-03-23 | ⤷ Subscribe | ⤷ Subscribe |
Teva Respiratory, Llc | CINQAIR | reslizumab | Injection | 761033 | 2016-03-23 | 6,056,957 | ⤷ Subscribe |
Teva Respiratory, Llc | CINQAIR | reslizumab | Injection | 761033 | 2016-03-23 | RE39548 | ⤷ Subscribe |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Patent Expiration |